Transgender adolescents rarely chose to discontinue gender-affirming hormone therapy, finds study

FHS
June 18, 2023
5:18 pm

A three-year-long retrospective cohort study of a single Atlanta hospital’s patient population found transgender and gender-diverse teenagers rarely chose to discontinue gender-affirming hormone therapy, according to a study being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Hot Flash Drug Succeeds in Two Pivotal Trials

SAN FRANCISCO — Novel agent elinzanetant relieved the frequency and severity of hot flashes in postmenopausal women in two nearly identical phase III trials, OASIS

May 21, 2024

How does the Mediterranean diet impact insulin resistance and sensitivity in obese individuals?

Researchers evaluate the associations between adherence to the Mediterranean diet, insulin secretion, resistance, and sensitivity in obese individuals.

October 30, 2023

Getinge’s heart assist pump shutdown problem given FDA Class I recall tag

Dive Brief: The U.S. Food and Drug Administration has categorized Getinge’s latest heart assist pump safety notice as a Class I recall. Getinge sent an

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.